| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-08-22 | Schwab Andrew J. Director, 10% Owner | Sale | -231,405 | -13.25%1,514,557 | $3.46 | $800,549 | View SEC filing | |
| 2025-08-22 | ROCKLAGE SCOTT M 10% Owner | Sale | -231,405 | -13.25%1,514,557 | $3.46 | $800,549 | View SEC filing | |
| 2025-02-28 | ARSENAULT KAITLYN Chief Financial Officer | Sale | -43,216 | -20.51%167,522 | $4.99 | $215,754 | View SEC filing | |
| 2024-11-20 | Diep Tuan Tu Chief Development Officer | Sale | -19,574 | -19.22%82,259 | $4.99 | $97,722 | View SEC filing | |
| 2024-11-19 | ARSENAULT KAITLYN Chief Financial Officer | Sale | -43,396 | -20.69%166,342 | $4.99 | $216,652 | View SEC filing | |
| 2024-11-19 | DHILLON PUNIT Chief Executive Officer | Sale | -82,910 | -20.09%329,823 | $4.99 | $413,925 | View SEC filing | |
| 2024-11-19 | Grayson Paul A. Director | Sale | -86,551 | -25.00%259,701 | $4.99 | $432,061 | View SEC filing | |
| 2024-09-13 | Schwab Andrew J. Director, 10% Owner | Sale | -266,337 | -2.62%9,913,168 | $6.57 | $1,750,352 | View SEC filing | |
| 2024-09-13 | ROCKLAGE SCOTT M 10% Owner | Sale | -266,337 | -2.62%9,913,168 | $6.57 | $1,750,352 | View SEC filing | |
| 2024-03-15 | ROCKLAGE SCOTT M 10% Owner | Purchase | +450,000 | +5.66%8,393,520 | $10.00 | $4,500,000 | View SEC filing | |
| 2024-02-02 | ROCKLAGE SCOTT M 10% Owner | Purchase | +5,206,074 | +190.18%7,943,520 | $2.31 | $12,026,031 | View SEC filing | |
| 2023-08-31 | DHILLON PUNIT Chief Executive Officer | Purchase | +881,000 | +3.55%25,683,957 | $0.02 | $16,475 | View SEC filing | |
| 2023-08-29 | DHILLON PUNIT Chief Executive Officer | Purchase | +881,000 | +2.17%41,554,828 | $0.02 | $16,475 | View SEC filing | |
| 2023-03-17 | Emerald Health Sciences Inc. 10% Owner | Purchase | -2,500,000 | -100.00%0 | N/A | N/A | View SEC filing | |
| 2020-08-13 | Emerald Health Sciences Inc. 10% Owner | Sale | -2,566,666 | -2.03%123,923,501 | $0.10 | $256,667 | View SEC filing | |
| 2020-08-11 | Emerald Health Sciences Inc. 10% Owner | Sale | -3,000,000 | -2.37%123,490,167 | $0.10 | $300,000 | View SEC filing | |
| 2020-08-11 | DHILLON PUNIT CEO | Purchase | +1,000,000 | +100.00%1,000,000 | $100000.00 | $100,000,000,000 | View SEC filing | |
| 2020-08-11 | HEPPELL JAMES L Director | Purchase | +500,000 | +100.00%500,000 | $50000.00 | $25,000,000,000 | View SEC filing | |
| 2018-02-21 | Emerald Health Sciences Inc. 10% Owner | Purchase | +35,400,000 | +147.50%59,400,000 | N/A | N/A | View SEC filing | |
| 2015-06-02 | McLaughlin Gerald W. Director | Purchase | +12,000 | +100.00%12,000 | $2.08 | $25,000 | View SEC filing | |
| 2015-04-10 | Ladin Brian D 10% Owner | Sale | -50,630 | -16.89%249,098 | $4.78 | $241,885 | View SEC filing |
1-21 of 21
